Komori
KYORIN Pharmaceutical (4569) · RiskMitigated

Impact of Foreign Exchange Rate Movements on Business Results

First written in FY2017. 3 of 6 entries say "Restated". Latest entry: FY2025.

6entries
9years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2017 – FY2019ReframedFY20202017: 120172018: 120182019: 120192020: 120202021: 020212022: 020222023: 020232024: 120242025: 12025
Same theme, other companies
Earnings impact from exchange-rate fluctuations and foreign-currency-denominated transactionsA theme 480 companies write about · 418 as a headwind · 20 as a tailwind

The whole theme swung hardest in 2025: 71 of 159 companies on the "Worse" side.

53 other companies' latest entry also says "Mitigated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 195 companies compared. The sentences above are computed from all 195.Comparing 200 of the theme's 494 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2025MitigatedAnnual report

    「Our group responds to financial market fluctuations by monitoring financial market conditions when formulating management plans, entering into foreign-exchange forward contracts and reviewing its funding methods.」

    The company specified measures to address financial market risks, including foreign-exchange rates, interest rates and purchase prices, by monitoring market conditions during management planning, entering into foreign-exchange forward contracts and reviewing funding methods.
  2. FY2024RestatedAnnual report

    「Fluctuations in foreign-exchange rates affect our group’s results of operations and financial position in import and export transactions. If financial markets fluctuate beyond expectations, our group’s results of operations and financial position may be materially affected by higher purchase prices, changes in pension assets, retirement benefit obligations and the valuation of shares held, among other factors.」

    The company continues to disclose financial market risks, including foreign-exchange fluctuations, purchase prices, pensions, retirement benefit obligations and the valuation of shares held.
  3. FY2020ReframedAnnual report

    「Fluctuations in foreign-exchange rates may have a material impact on our group’s results of operations and financial position in import and export transactions. In addition, if fluctuations in foreign-exchange rates, interest rates or equity markets cause changes in the value of pension assets, retirement benefit obligations or shares held, they may have a material impact on our group’s results of operations and financial position.」

    The disclosure of foreign-exchange risk was expanded to include financial market risks involving interest rates, equity markets, pension assets, retirement benefit obligations and changes in the valuation of shares held.
  4. FY2019RestatedAnnual report

    「The Group engages in exports and imports with overseas markets, and fluctuations in foreign exchange rates affect our sales and other items.」

    The company continues to disclose the risk of foreign-exchange fluctuations associated with overseas imports and exports.
  5. FY2018RestatedAnnual report

    「The Group engages in exports and imports with overseas markets, and fluctuations in foreign exchange rates affect our sales and other items.」

    The company continues to disclose the risk of foreign-exchange fluctuations associated with overseas imports and exports.
  6. FY2017First statedAnnual report

    「The Group engages in exports and imports with overseas markets, and fluctuations in foreign exchange rates affect our sales and other items.」

    Foreign exchange fluctuations associated with overseas imports and exports are identified as a risk to sales and other items.
Moved together

"Rebuilding the Human Resources Management System and Strengthening Talent Development" moved the same way as this thread, in the same document, in 2 of its 6 moves.

2★1
  1. ★This thread
  2. 1Rebuilding the Human Resources Management System and Strengthening Talent Development2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for KYORIN Pharmaceutical yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Impact of Foreign Exchange Rate Movements on Business Results | KYORIN Pharmaceutical Co.,Ltd. (4569) | Komori